Factbox-Anthropic’s public benefit fund and how it compares with other big philanthropic efforts Investing.com · News 19m ago
Guggenheim raises Rapport Therapeutics price target to $70 on trial data Investing.com · News 21m ago
ACCESS Newswire at LD Micro event: growth plan shifts to recurring revenue Investing.com · News 33m ago
MannKind at Chardan’s 10th Annual Healthcare Conference: pipeline broadens Investing.com · News 34m ago
The healthcare sector is getting a safe haven boost. This one stock is headed for a long-term breakout CNBC · Markets 42m ago